We are live on
!
Find out more
PCM
Poehling Capital Management Portfolio holdings
AUM
$466M
1-Year Est. Return
24.17%
This Fund
S&P 500
This Quarter
Est. Return
+9.11%
1 Year Est. Return
+24.17%
3 Year Est. Return
+70.93%
5 Year Est. Return
+69.6%
10 Year Est. Return
–
AUM
$286M
AUM Growth
+$33.6M
(+13%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
5.17%
Top 10 Holdings %
Top 10 Hldgs %
26.81%
Holding
167
New
37
Increased
38
Reduced
59
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$4.92M |
| 2 |
MTTR
Matterport, Inc. Class A Common Stock
MTTR
|
+$1.83M |
| 3 |
Merck
MRK
|
+$1.66M |
| 4 |
Paysafe
PSFE
|
+$1.5M |
| 5 |
Madison Square Garden
MSGS
|
+$1.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$4.38M |
| 2 |
Affiliated Managers Group
AMG
|
+$2.42M |
| 3 |
Warner Bros
WBD
|
+$2.04M |
| 4 |
Smith & Wesson
SWBI
|
+$1.49M |
| 5 |
Booking.com
BKNG
|
+$1.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 35.36% |
| 2 | Healthcare | 12.21% |
| 3 | Communication Services | 9.13% |
| 4 | Technology | 7.54% |
| 5 | Consumer Staples | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$950B
| $3.43M | 1.2% |
22,511
-212
| -0.9% | -$30.5K |
|
27
Apollo Global Management
APO
$73.4B
| $3.38M | 1.18% |
71,800
+8,280
| +13% | +$403K |
|
|
28
Merck
MRK
$318B
| $3.34M | 1.17% |
45,455
+22,571
| +99% | +$1.66M |
|
|
RTN
29
DELISTED
Raytheon Company
RTN
| $3.33M | 1.17% |
43,140
-1,087
| -2% | -$84K |
|
30
Intel
INTC
$513B
| $3.25M | 1.14% |
50,831
-3,264
| -6% | -$195K |
|
31
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
| $3.01M | 1.05% |
88,413
+4,058
| +5% | +$130K |
|
32
PepsiCo
PEP
$190B
| $3.01M | 1.05% |
21,253
-90
| -0.4% | -$12.3K |
|
|
RBAC
33
DELISTED
RedBall Acquisition Corp.
RBAC
| $2.97M | 1.04% |
298,899
+8,124
| +3% | +$85.7K |
|
34
GraniteShares Gold Shares
BAR
$1.46B
| $2.95M | 1.03% |
173,847
+20,945
| +14% | +$373K |
|
35
Pfizer
PFE
$153B
| $2.93M | 1.03% |
80,840
+2,746
| +4% | +$97.5K |
|
36
Bausch Health
BHC
$2.34B
| $2.82M | 0.99% |
88,872
+16,050
| +22% | +$471K |
|
37
BP
BP
$107B
| $2.72M | 0.95% |
111,605
+36,400
| +48% | +$877K |
|
38
ProShares Ultra Silver
AGQ
$1.38B
| $2.7M | 0.95% |
65,787
+27,973
| +74% | +$1.36M |
|
|
WPF.U
39
DELISTED
Foley Trasimene Acquisition Corp.
WPF.U
| $2.7M | 0.95% |
252,731
-3,257
| -1% | -$37.6K |
|
40
American International
AIG
$41.3B
| $2.7M | 0.95% |
58,441
+4,805
| +9% | +$208K |
|
41
Carlyle Group
CG
$17.2B
| $2.59M | 0.91% |
70,370
-9,289
| -12% | -$326K |
|
42
Johnson & Johnson
JNJ
$625B
| $2.52M | 0.88% |
15,300
-171
| -1% | -$27.7K |
|
43
Bank of America
BAC
$442B
| $2.5M | 0.87% |
64,575
-552
| -0.8% | -$19K |
|
44
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $2.49M | 0.87% |
89,470
+7,245
| +9% | +$209K |
|
|
45
Affiliated Managers Group
AMG
$9.76B
| $2.45M | 0.86% |
16,438
-18,504
| -53% | -$2.42M |
|
46
Amgen
AMGN
$222B
| $2.37M | 0.83% |
9,539
-549
| -5% | -$131K |
|
|
BNY
47
Bank of New York Mellon
BNY
$107B
| $2.28M | 0.8% |
48,240
+9,256
| +24% | +$407K |
|
48
Phillips 66
PSX
$81.4B
| $2.21M | 0.77% |
27,051
-1,839
| -6% | -$144K |
|
49
Enbridge
ENB
$112B
| $2.19M | 0.77% |
60,288
+24,518
| +69% | +$862K |
|
50
AB InBev
BUD
$165B
| $2.19M | 0.77% |
34,884
-1,101
| -3% | -$71.1K |
|
Similar funds
UC
JHC
HP
ACGA
PC
VCM
SP
SCA
Poehling Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Poehling Capital Management held 167 positions worth $286M, up 13% from $252M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Poehling Capital Management deployed $14.8M of net new capital in Q1 2021, opening 37 new positions and adding to 38 existing holdings. Its largest new stake was Viatris: 302,063 shares worth $4.22M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Paramount Global Class B, an estimated $4.38M trimmed.
- Poehling Capital Management's largest Q1 2021 buy was Viatris: 302,063 shares worth $4.22M.
- Poehling Capital Management added most to Merck in Q1 2021, an estimated $1.66M increase.
- Poehling Capital Management's biggest Q1 2021 reduction was Paramount Global Class B, cutting an estimated $4.38M.
- Poehling Capital Management fully exited Smith & Wesson in Q1 2021, selling an estimated $1.49M.
- Poehling Capital Management's ten largest holdings make up 27% of its $286M portfolio in Q1 2021.
- Poehling Capital Management opened 37 new positions and closed 10 in Q1 2021.
- Poehling Capital Management's portfolio value rose 13% quarter-over-quarter to $286M.
Based on Poehling Capital Management's 13F filing for Q1 2021, filed 11 May 2021.